These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 32457377)
1. Discovery of a new sialic acid binding region that regulates Siglec-7. Yamakawa N; Yasuda Y; Yoshimura A; Goshima A; Crocker PR; Vergoten G; Nishiura Y; Takahashi T; Hanashima S; Matsumoto K; Yamaguchi Y; Tanaka H; Kitajima K; Sato C Sci Rep; 2020 May; 10(1):8647. PubMed ID: 32457377 [TBL] [Abstract][Full Text] [Related]
2. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. Avril T; Floyd H; Lopez F; Vivier E; Crocker PR J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178 [TBL] [Abstract][Full Text] [Related]
3. The conserved arginine residue in all siglecs is essential for Siglec-7 binding to sialic acid. Yoshimura A; Hatanaka R; Tanaka H; Kitajima K; Sato C Biochem Biophys Res Commun; 2021 Jan; 534():1069-1075. PubMed ID: 33248687 [TBL] [Abstract][Full Text] [Related]
4. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9. Yamaji T; Teranishi T; Alphey MS; Crocker PR; Hashimoto Y J Biol Chem; 2002 Feb; 277(8):6324-32. PubMed ID: 11741958 [TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells. Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961 [TBL] [Abstract][Full Text] [Related]
6. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression. Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734 [TBL] [Abstract][Full Text] [Related]
7. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. Angata T; Varki A J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860 [TBL] [Abstract][Full Text] [Related]
9. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Nicoll G; Avril T; Lock K; Furukawa K; Bovin N; Crocker PR Eur J Immunol; 2003 Jun; 33(6):1642-8. PubMed ID: 12778482 [TBL] [Abstract][Full Text] [Related]
10. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. Nicoll G; Ni J; Liu D; Klenerman P; Munday J; Dubock S; Mattei MG; Crocker PR J Biol Chem; 1999 Nov; 274(48):34089-95. PubMed ID: 10567377 [TBL] [Abstract][Full Text] [Related]
13. Chemical Synthesis and Evaluation of a Disialic Acid-Containing Dextran Polymer as an Inhibitor for the Interaction between Siglec 7 and Its Ligand. Yamaguchi S; Yoshimura A; Yasuda Y; Mori A; Tanaka H; Takahashi T; Kitajima K; Sato C Chembiochem; 2017 Jul; 18(13):1194-1203. PubMed ID: 28374980 [TBL] [Abstract][Full Text] [Related]
14. High-affinity ligands of Siglec receptors and their therapeutic potentials. Magesh S; Ando H; Tsubata T; Ishida H; Kiso M Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229 [TBL] [Abstract][Full Text] [Related]
15. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins. Bornhöfft KF; Goldammer T; Rebl A; Galuska SP Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010 [TBL] [Abstract][Full Text] [Related]
16. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. Ikehara Y; Ikehara SK; Paulson JC J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262 [TBL] [Abstract][Full Text] [Related]
17. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. Floyd H; Ni J; Cornish AL; Zeng Z; Liu D; Carter KC; Steel J; Crocker PR J Biol Chem; 2000 Jan; 275(2):861-6. PubMed ID: 10625619 [TBL] [Abstract][Full Text] [Related]
18. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2. Yu Z; Maoui M; Wu L; Banville D; Shen S Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044 [TBL] [Abstract][Full Text] [Related]
19. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily. Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856 [TBL] [Abstract][Full Text] [Related]
20. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. Sgroi D; Nocks A; Stamenkovic I J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]